Physician

Katherine Suzanne Tille, M.D.

According to 2025 Medicare claims, Katherine Tille, M.D. (NPI: 1528155215) practices allergy/immunology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is ALLERGY & ASTHMA CENTER OF WESTERN COLORADO P C (NPI: 1922122241; TIN: 840839115) and primary practice location at 81501-6129. Tille is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tille's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 293 traditional Medicare patients, billed 6,569 HCPCS/CPT codes, and received $70,762 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,230 prescription claims across 243 beneficiaries totaling $459,901 in drug costs, led by Xolair (Omalizumab). DME data shows 75 claims. Open Payments data shows 2 records totaling $285. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $40,825 to $70,762. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,481 to $459,901. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	217	3,615	$40,825
2020	258	5,969	$54,099
2021	274	5,381	$53,315
2022	269	5,029	$53,222
2023	276	5,898	$58,197
2024	293	6,569	$70,762

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	45	119	$10,481
2019	154	614	$105,569
2020	181	795	$221,093
2021	199	911	$261,887
2022	216	946	$316,045
2023	195	958	$414,381
2024	243	1,230	$459,901

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$144
2023	N/R	46	$103,015
2024	N/R	75	$169,461

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	80	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	109	$55
94010	Test to measure expiratory airflow and volume	56	59	$18
95117	Professional service for multiple injections of allergen	59	473	$8
95004	Test for allergy using allergenic extract	59	2,597	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	25	700	$83,946
Dupixent Syringe	Dupilumab	19	532	$66,052
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	89	3,056	$62,261
Dupixent Pen	Dupilumab	12	364	$49,812
Breo Ellipta	Fluticasone/Vilanterol	61	2,190	$28,979

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$115,356
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	11	$52,092
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	25	$1,762
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	26	$250

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$285	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Katherine Suzanne Tille, M.D.?

Tedicare shows public-source Medicare data for Katherine Suzanne Tille, M.D. (NPI 1528155215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Katherine Suzanne Tille, M.D. have ACO affiliation data?

Katherine Suzanne Tille, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Katherine Suzanne Tille, M.D.?

Katherine Suzanne Tille, M.D. is linked to ALLERGY & ASTHMA CENTER OF WESTERN COLORADO P C (billing NPI 1922122241) in the available physician profile data.

Does Katherine Suzanne Tille, M.D. have Open Payments data?

Katherine Suzanne Tille, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.